Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on The Reykjavik Daily.
Europe’s Urban Mine: International E‑waste Day 2025 Highlights the Value Hidden in Our Electronics
14 October 2025, Geneva, Switzerland - On International E‑waste Day 2025, the United Nations Institute for Training and Research (UNITAR) joins international partners in drawing attention to the growing economic and environmental importance of...
Owner: United Nations
Tourism Source Market to Surge USD 1.1 Trillion by 2032, Size, Share, Emerging Trends, Key Growth Drivers
Based on booking channels, the mobile application segment had the major Tourism Source Market Share and is likely to remain dominant during the forecast period. WILMINGTON, DE, UNITED STATES, October 15, 2025 /EINPresswire.com/ -- The Tourism...
Prime Minister Carney meets with Prime Minister of Iceland Kristrún Frostadóttir
CANADA, September 26 - Today, the Prime Minister, Mark Carney, met with the Prime Minister of Iceland, Kristrún Frostadóttir, on the margins of the Global Progress Action Summit in London. Prime Minister Carney and Prime Minister Frostadóttir...
Owner: Canadian Government
Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025
ZUG, Switzerland, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet...
The Global Myeloma Community Mourns the Passing of IMF Co-Founder Dr. Brian G.M. Durie
LOS ANGELES, Oct. 14, 2025 (GLOBE NEWSWIRE) -- It is with great sadness that the International Myeloma Foundation (IMF) shares the news of the death of Dr. Brian G.M. Durie, co-founder of the organization. A Media Snippet accompanying this...
PureCycle Receives REACH Certification, Unlocking EU Sales of PureFive™ Resin
ORLANDO, Fla., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT), announced today it has received the REACH Certificate of Compliance, allowing the company to sell PureFive™ resin to customers in the European Union. The...
What if? “Strategic Competition” vs. “Selective Cooperation”
Back to Publications April 2025 Central Arctic Ocean Roundtable event at Tongji University. Photo: Min Pan A prominent Western narrative portrays China as eagerly pursuing economic and strategic goals in the Arctic. U.S. Defense Department...
FIDELITY to Premiere at Chelsea Film Festival: A Daughter’s Search for Connection in the Age of Artificial Intimacy
New York, Oct. 13, 2025 (GLOBE NEWSWIRE) -- A young actress steps into the role of a dying man's estranged daughter, and finds herself confronting the unresolved loss of her own father. FIDELITY, the debut feature from writer-director Roberto...
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
LONDON and REYKJAVIK, Iceland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe...
Amaroq Ltd to Present at the Metals & Mining Virtual Investor Conference October 8th
TORONTO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Amaroq Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ, OTCQX: AMRQF), an independent mine development corporation focused on unlocking Greenland’s mineral potential, is pleased to announce that Eldur Olafsson,...
Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy
Successful meeting with FDA enables advancement into pivotal development with Privosegtor in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Oculis will launch the PIONEER Program, which includes multiple...
Míla Holding hf.: Confirmation of the report on the financial obligations of MILA 300929 bond
Míla Holding hf.: Confirmation of the report on the financial obligations of MILA 300929 bond Enclosed is a confirmation by KPMG ehf. on Míla Holding hf.'s report on financial obligations relating to the issuance of MILA 300929 bond. The...
AVEM AERO Expands Flight Support to Intercontinental Missions for Private Pilots Flying Small Aircraft
AVEM AERO expands services with intercontinental flight support for private pilots, enabling long-distance missions. TALLIN, ESTONIA, October 9, 2025 /EINPresswire.com/ -- AVEM AERO, the Estonian aviation services provider specializing in OCC...
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
REYKJAVIK, Iceland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines...
European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech’s Proposed Biosimilar to Simponi® (golimumab) with Advanz Pharma as Commercialization Partner
REYKJAVIK, ICELAND and LONDON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited...
Higher Levels of Trust Determine 2025 Fortune 100 Best Companies to Work For Europe
Oakland, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Great Place To Work® announced the 2025 Fortune 100 Best Companies to Work For™ Europe, marking its second year of partnering with Fortune Europe. To select the list, Great Place To Work surveyed...
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
REYKJAVIK, Iceland, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its commercialization...